期刊文献+

普伐他汀短期治疗对慢性心衰患者心功能的影响 被引量:41

Effect of short-term pravastatin therapy on heart function in patients with chronic heart failure
下载PDF
导出
摘要 目的 :探讨短期应用他汀类降脂药普伐他汀对慢性心衰患者心功能的作用。方法 :64例慢性心力衰竭患者 ,随机分为普伐他汀治疗组 ( 3 4例 )和对照组 ( 3 0例 ) ,对照组给予强心、利尿、扩血管治疗 ,治疗组在此基础上加用普伐他汀 ,剂量为 2 0mg ,每晚 1次 ,疗程 8周 ,测定左室射血分数、血清肿瘤坏死因子 -α和白介素 -6及其变化。结果 :普伐他汀治疗组与对照组比较 ,血清胆固醇有适度的下降 ;治疗后两组左室射血分数均有所提高 ,但普伐他汀组明显 ,与对照组比较 ,有统计学差异 ;治疗后与治疗前比较 ,普伐他汀组血清肿瘤坏死因子和白介素 -6的降低比对照组更明显。结论 :短期普伐他汀治疗能改善慢性心衰患者心功能和神经激素的平衡失调状况。 Aim:To study the effect of short-term pravastatin therapy on heart function in patients with chronic heart failure (CHF).Methods:Sixty-four patients with CHF were randomly divided into 2 groups. Patients in control group (n=30) were given inotropic agent, diuretic, and vasodilator therapy. Patients in pravastatin group (n=34) were given pravastatin 20 mg every evening for 8 weeks on the basis of the therapy in control group. The left ventricular ejection fraction and the concentration of tumor necrosis factor alpha (TNF alpha) and inerleukin-6 (IL-6) were measured. Results:After 8 weeks, patients receiving provastatin exhibited a modest reduction in serum cholesterol level compared with control group. LVEF was increased in all patients after therapy but it was increased more apparently in provastatin-treated group than that in control group. The level of TNF-alpha and IL-6 was decreased after provastatin treatment.Conclusion:Short-term pravastatin therapy can improve cardiac function and neurohormonal imbalance.
作者 张育民
机构地区 长沙市第三医院
出处 《上海医药》 CAS 2004年第6期275-276,共2页 Shanghai Medical & Pharmaceutical Journal
关键词 普伐他汀 短期治疗 慢性心衰 心功能 TNF-Α IL-6 provastatin congestive heart failure TNF-alpha IL-6
  • 相关文献

参考文献4

  • 1Torre - Amione - G, Kapadis - S, Benedia - S, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction :a report from the Study of Left Ventricular Dysfunction(SOLVD) J Am Coil Cardiol, 1996,27 (5): 1201.
  • 2Ho KKL, Anderson KM, Kannel WB. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation, 1993,88 ( 1 ): 107.
  • 3The Long- Term Intervention with Pravastatin in Ischaemic Disease(LIPIS) Study Group. N Engl J Med, 1998 ;339 (19): 1349.
  • 4顾水明,吴宗贵,魏盟.他汀类药物治疗心力衰竭的作用探讨[J].国外医学(心血管疾病分册),2003,30(6):358-360. 被引量:13

二级参考文献12

  • 1Bauersachs J, Galuppo P, Fraccarollo D, et al. Circulation,2001; 104(9): 982-985.
  • 2Hayashidani S, Tsutsui H, Shiomi T, et al. Circulation,2002;105(7):868-873.
  • 3Louis AA, Manousos IR, Coletta AA, et al. Eur Heart Fail, 2002; 4(1): 111-116.
  • 4Khatta M, Alexander BS, Krichten CM, et al. Ann Intern Med, 2000; 132(8) .. 636-640.
  • 5Rauchhaus M, Coats AJ, Anker SD. Lancet, 2000; 356(9233) : 930-933.
  • 6Sacks FM, Pfeffer MA, Moye LA, et al. N Engl J Med,1996;335(14): 1001-1009.
  • 7The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med, 1998; 339(19); 1349-1357.
  • 8Kureishi Y, Luo Z, Shiojima I, et al. Nat Med, 2000; 6(9): 1004-1010.
  • 9Strehlow K, Wassmann S, Bohm M, et al. Ann Med,2000; 32(6): 386-389.
  • 10Pehlivanidis AN, Athyros VG, Demitriadis DS, et al. Atherosclerosis, 2001 - 157(2) :463-469.

共引文献12

同被引文献224

引证文献41

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部